疗效和安全性的临床试验
总计417023个结果
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Genentech, Inc.; Pharmacyclics LLC.招聘中非霍奇金淋巴瘤 | 惰性非霍奇金淋巴瘤 | 粘膜相关淋巴组织的 Ann Arbor II 期结外边缘区淋巴瘤 | Ann Arbor II 期滤泡性淋巴瘤 | Ann Arbor II 期淋巴结边缘区淋巴瘤 | Ann Abor III 期 B 细胞非霍奇金淋巴瘤 | 粘膜相关淋巴组织的 Ann Arbor III 期结外边缘区淋巴瘤 | Ann Arbor III 期滤泡性淋巴瘤 | Ann Arbor III 期淋巴结边缘区淋巴瘤 | Ann Arbor IV 期 B 细胞非霍奇金淋巴瘤 | 粘膜相关淋巴组织的 Ann Arbor IV 期结外边缘区淋巴瘤 | Ann Arbor IV 期滤泡性淋巴瘤 | Ann Arbor IV 期淋巴结边缘区淋巴瘤 及其他条件美国
-
Aga Khan UniversityBill and Melinda Gates Foundation; Benazir Income Support Programme (BISP)完全的
-
Vibeke KoushedeDanish Cancer Society; Copenhagen Trial Unit, Center for Clinical Intervention Research完全的
-
PT Bio Farma完全的
-
AstraZeneca完全的
-
Jonkoping UniversityLund University; Göteborg University招聘中
-
Yale University完全的
-
Beijing Tongren HospitalBeijing Institute of Otolaryngology; Shanghai Johnson & Johnson Pharmaceuticals, Ltd.未知
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)邀请报名
-
Elizabeth Glaser Pediatric AIDS FoundationAga Khan University; Development Media International; Ministry of Health, Community Development... 和其他合作者完全的
-
Massachusetts General HospitalAgency for Healthcare Research and Quality (AHRQ)完全的质量改进 | 患者安全 | 用药错误 | 医疗记录系统,计算机化美国
-
Menzies School of Health ResearchCharles Darwin University; Northern Territory of Australia as represented by the Department... 和其他合作者招聘中
-
University of HohenheimGerman Federal Ministry of Education and Research完全的
-
Muhimbili University of Health and Allied SciencesKarolinska Institutet; Imperial College London; Medical Research Council; Ludwig-Maximilians - University... 和其他合作者完全的艾滋病病毒 | 安全 | 免疫原性 | 疫苗坦桑尼亚, 莫桑比克
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Janssen, LP完全的CD20阳性 | Ann Arbor II 期滤泡性淋巴瘤 | Ann Arbor III 期滤泡性淋巴瘤 | Ann Arbor IV 期滤泡性淋巴瘤 | 1 级滤泡性淋巴瘤 | 2 级滤泡性淋巴瘤 | 3a 级滤泡性淋巴瘤 | Ann Arbor II 期边缘区淋巴瘤 | Ann Arbor III 期边缘区淋巴瘤 | Ann Arbor IV 期边缘区淋巴瘤美国
-
Karolinska InstitutetStockholm University; Sigrid Therapeutics AB, Sweden完全的安全问题
-
Lotus Pharmaceutical未知该研究的目的是评估 Acarmet(盐酸二甲双胍 500 毫克)的疗效和安全性 | 加上阿卡波糖 50 毫克片剂)每天三次对比阿卡波糖 50 毫克每天三次超过 16 周 | 患有 2 型糖尿病的受试者。台湾
-
University of PennsylvaniaAnesthesia Patient Safety Foundation完全的
-
University of HohenheimGerman Federal Ministry of Education and Research完全的
-
University Hospital, Basel, Switzerland完全的
-
Mayo ClinicNational Cancer Institute (NCI)主动,不招人弥漫性大 B 细胞淋巴瘤 | 惰性非霍奇金淋巴瘤 | Ann Arbor II 期弥漫性大 B 细胞淋巴瘤 | Ann Arbor III 期弥漫性大 B 细胞淋巴瘤 | Ann Arbor IV 期弥漫性大 B 细胞淋巴瘤 | 具有 MYC 和 BCL2 或 BCL6 重排的高级别 B 细胞淋巴瘤 | 伴有 MYC、BCL2 和 BCL6 重排的高级别 B 细胞淋巴瘤 | Ann Arbor II 期滤泡性淋巴瘤 | Ann Arbor III 期滤泡性淋巴瘤 | Ann Arbor IV 期滤泡性淋巴瘤 | 具有 MYC 和 BCL2 和/或 BCL6 重排的高级别 B 细胞淋巴瘤 | Ann Arbor II 期边缘区淋巴瘤 | Ann Arbor... 及其他条件美国
-
Catholic Kwandong UniversityKorea University Guro Hospital完全的
-
Johann Wolfgang Goethe University HospitalCSL Behring; B. Braun Melsungen AG; Vifor Pharma; Fresenius Kabi招聘中
-
Shanghai Cell Therapy Group Co.,LtdShanghai Mengchao Cancer Hospital尚未招聘
-
The First Affiliated Hospital of Soochow University邀请报名